Exact Mass: 1106.522527

Exact Mass Matches: 1106.522527

Found 10 metabolites which its exact mass value is equals to given mass value 1106.522527, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Withanoside IX

27-O-beta-D-glucopyranosyl (1-6)-beta-D-glucopyranosylpubesenolide 3-O-beta-D-glucopyranosyl (1-6)-beta-D-glucopyranoside

C52H82O25 (1106.5144922)


   
   

3-O-beta-D-xylopyranosyl(1->3)-[beta-D-galactopyranosyl(1->2)]-beta-D-glucuronopyranosyl-21-O-benzoyl-28-O-acetylbarringtogenol C|acutanguloside B

3-O-beta-D-xylopyranosyl(1->3)-[beta-D-galactopyranosyl(1->2)]-beta-D-glucuronopyranosyl-21-O-benzoyl-28-O-acetylbarringtogenol C|acutanguloside B

C56H82O22 (1106.5297472)


   
   

3-O-beta-(alpha-L-Rhamnopyranosyl(1-2)-beta-D-xylopyranosyl(1-2)-beta-D-glucuronopyranosyl)-30-hydroxy-25-formylolean-18-ene-22-beta-O-syringate

3-O-beta-(alpha-L-Rhamnopyranosyl(1-2)-beta-D-xylopyranosyl(1-2)-beta-D-glucuronopyranosyl)-30-hydroxy-25-formylolean-18-ene-22-beta-O-syringate

C56H82O22 (1106.5297472)


   
   

Pasireotide (acetate)

Pasireotide (acetate)

C60H70N10O11 (1106.522527)


Pasireotide (SOM230) acetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide acetate can suppress GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing's disease. Pasireotide acetate also exhibits antisecretory, antiproliferative, and proapoptotic activity[1][2][3].

   

(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-{[(2r,3r,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-2-[(1'r,2s,2's,3s,4s,4's,5r,7's,8'r,9's,10'r,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-3,10',16'-trioloxy]-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-3-yl]oxy}-2-methyloxan-3-yl acetate

(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-{[(2r,3r,4s,5r,6r)-5-hydroxy-6-(hydroxymethyl)-2-[(1'r,2s,2's,3s,4s,4's,5r,7's,8'r,9's,10'r,12's,13'r,14'r,16'r)-5,7',9',13'-tetramethyl-4-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-3,10',16'-trioloxy]-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-3-yl]oxy}-2-methyloxan-3-yl acetate

C52H82O25 (1106.5144922)